On MIT Holding’s website,
you’ll find the tagline “Leading the way for today and the next generation.”
Catchy, but what exactly does that mean? MIT Holding is a single-source
provider for in-home medical recovery services. Sounds simple enough, but it’s
an innovative business model based on a quiet evolution within the healthcare
industry and the company’s foresight to prepare for and capitalize on impending
industry changes.
MIT Holdings partners with
hospitals, physicians, facility-based providers, pharmaceutical manufacturers
and other contractual affiliates to provide patients with sweeping out-patient
services. The company meets and/or exceeds major U.S. health insurance
requirements, which enables them to directly bill and receive payments from
carriers on behalf of the patient as well as company agents and facilitators.
Here’s how the actual
recovery services platform works. Upon his or her release from the hospital, a
patient meets with a discharge planner who is responsible for helping the
patient transition to the next level of care. Depending on the procedures
performed, this transition can take weeks, months or years, and in some cases
for the remainder of the patient’s life.
When in-home
rehabilitation is recommended, the planner would refer the patient to MIT
Holding. Through its portfolio of services, MIT Holding then provides its
comprehensive medical products through a concierge type service at no
additional cost to the patient.
The patient may need a
range of services from ambulatory, infusion, durable medical equipment (DME),
pharmacy services, improved sanitary spaces, transportation and other recovery
services or products. MIT Holding can arrange any or all of these services for
the patient. This contractual model creates numerous revenue streams for MIT
Holdings along with tremendous cost savings for the patient and insurance
company.
“The goal is to provide a
non-stressful healing environment possible. The belief is recovery will happen
much faster because we meet patients in their home environment, not in a
stressful sterile medical facility. The patient completes recovery quicker,
insurance company pays less over time creating a win-win situation,” says
William Nalley, president of the Orsay Group, Inc., and IR advisor for MIT
Holding.
The Affordable Care Act
creates pressure for hospitals and doctors to lower costs, and as a result,
more people are being discharged earlier from hospitals to reduce the cost of
patient care. The cost-saving aspects of MIT Holding’s innovative platform are
part of the reason the company believes its business model will be a solid and
widespread component of the healthcare industry.
“The Affordable Care Act
is a positive for us … one thing it is requiring of hospitals, doctors and
medical care in general, is lower prices for services. For the patient, that
typically equates to a quicker exit from the hospital or medical facility.
We’re the company ¬with our arms open wide saying ‘come to us, we’ll pick up
where they left off.’ Imagine if on the last day of your hospital stay you
phoned downstairs to the concierge desk and asked: ‘Can you please arrange
everything for my home recovery please?’ MIT representatives will come to your
room and meet with you to make those arrangements,” Nalley explains.
MIT Holding’s model is an
active model. Through its current portfolio of services, the company can
arrange for patient pharmaceuticals, intravenous infusions, medical management
services, in-home or ambulatory center therapies. The durable medical equipment
services (DME) enable the company to offer for sale or rent, home medical
equipment, from crutches to hospital beds.
MIT Holding has beta
tested its single-source provider concept in Georgia, and to management’s
knowledge, is the first to provide this type of comprehensive service within
the home medical services industry. The company’s goal is to use its
industry-pioneering business model to maintain a number one position in this
new industry concept and expand with a nationwide footprint via strategic
acquisitions. To achieve this goal a one acquisition per each quarter is the
2015 corporate goal.
“We have the platform for
these services in place and we’re ready to duplicate state-by-state,” says MIT
Holding chairman and CEO Walter Drakeford. “It’s a tall order to fill, but the
company has a clearly defined plan to achieve this mission. The business model
is more than gobbling up the first acquisition target to come along. At the
core of this precision-based strategy is facility accreditation.”
Accreditation ensures that
a facility adheres to certain procedures and guidelines set by each state to
insure services and billing are correctly rendered. It’s basically a way to
make sure people aren’t opening up companies in the garage of their homes and
billing services for deceased patients.
The accreditation process
is extremely thorough, taking into consideration various information in 12
different divisions and covering everything from operations to billing,
finances and small day-to-day activities. It’s this meticulousness that deters
many medical facilities from ever becoming accredited. While it’s not mandatory
that facilities become accredited, every supplier of medical equipment has to be
accredited to be able to contract with Medicare. Additionally, accreditations
must be renewed every two years.
This accreditation is an
integral part for MIT Holding’s relationship with its more than 130 insurance
provider partners. One of MIT Holding’s affiliates started its accreditation
process January 1 to prepare for the June 6, 2015, expiration.
“Preparing for [the
accreditation] on the company’s end is something that is time consuming and
difficult, but it’s making sure that we have everything in place; which we do,”
stated a representative assisting in MIT Holding affiliates accreditation
renewal process. “It’s important that the accreditation is passed and every
employee is up to par in terms of what the company stands for and what the
company requires us to do.”
In fact, if the affiliate
had chosen not to renew its accreditation, MIT Holding would have scrapped the
partnership; here’s why. The Affordable Care Act does not affect the
accreditation process. As such, the accreditation itself has helped
legitimately operating companies while unraveling the operations of those that
were not.
For example, at one time,
the cost of care for patients on oxygen was never capped-out. The insurance
company could be billed for the oxygen for as long as the patient lived,
whether or not the supplying company ever had contact with the patient. Under
the Affordable Care Act, oxygen gets capped out at 36 months. At this point,
the supplier has to maintain contact with that patient to make sure they indeed
are alive and in need of oxygen. In essence, the Affordable Care Act came in
and cleaned house.
“An accreditation sticker
on your door shows that you are a reputable company – that you do things beyond
the norm in terms of standards. You have had a third party come in and review
everything and they have stamped you with a seal of excellence. The
accreditation process now has become something that everyone strives to have,
not only for insurance reasons but also to show to the community the physicians
and the patients that you are a legitimate company upholding the highest
patient standards,” says Drakeford.
Here’s where it ties back
to MIT Holding. As earlier noted, MIT Holding’s aggressive expansion strategy
calls for an acquisition per quarter – however, acquisition or affiliate
targets lacking accreditation or not in the process of doing so won’t get a second
look from MIT Holding. And it’s been that way for years, according to
Drakeford.
“MIT had the foresight two
years ago to look at the Affordable Care Act and see the benefits and how to
achieve the best results for the company, our patients and our shareholders by
adhering to accreditation standards and exemplifying those requirements for
anybody we bring on board to duplicate our platform in other states,” he says.
“As MIT continues to grow, the affiliations and affiliates that we work with
must be accredited. If you’re not professionally respected in your category,
you’re not an MIT candidate.”
The company expects that
in the next 5 to 10 years it will be mandatory that everyone will be
accredited. If true, the requirement would squeeze the number of people that
are entering the industry because the standards and expense will be too high.
On that note, MIT Holding will be ahead of the game.
“Whether it be on the DME
side, the pharmacy side, ambulatory side or infusion side we are seeing certain
criteria starting to slowly come into play that in the next 10 years will be
factored into whether a company will succeed or fail,” says Drakeford.
MIT Holding plans to
duplicate its platform across the U.S. by assembling a portfolio of key
affiliates and acquisitions that not only meet accreditation standards, but MIT
Holding standards as well.
Among several other
criteria, MIT Holding is looking for profitable acquisition targets with a
spotless billing history and strong management with an established set of
internal controls in place. Accreditation is also a requirement, though
companies in the process of accreditation or positioned to initiate the process
will be considered. MIT Holding has a few acquisition targets that fit the bill
and that are currently undergoing due diligence.
In June, 2014, MIT Holding
achieved its first profitable quarter in six years thanks to corporate
re-organization initiated in fiscal year 2011. Each MIT Holding subsidiary is
now operating with objectives of a 32% net profit. The MIT concept can still
deliver services and goods for less than the local medical facility.
Leveraging this improved
position, MIT Holding has developed a platform years ahead of its time. As
hospitals discharge patients earlier to lower hospital costs, and as
accreditation moves toward potential mandate status rather than an option, the
company’s strict accreditation policy adds power to its charge at the head of
the pack. With patient care in order, MIT Holding is now focusing on
shareholder value.
“The accreditation is an
example of the height of the demands MIT Holding has on anybody affiliated with
the company, which ultimately will reflect through to revenues, shareholder and
company valuation,” says Nalley. “We’re now in a position that we can duplicate
what’s occurred in Georgia in any other state in the country. MIT makes an
acquisition of a facility within that target state, bringing them under our
umbrella – and we’re now marketing in that state. Growth of MIT Holding will be
the ultimate reward to the shareholder.”
For more information,
visit www.mitholdingsinc.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
No comments:
Post a Comment